Breakthrough in COVID-19 Research: Human Enzyme KLK5 Plays Key Role in Virus Transformation

As COVID-19 infections continue to rise worldwide, particularly with the emergence of the KP.3 variant, researchers have made a significant discovery in understanding the virus’s behavior. The COVID-19 virus uses spike proteins, shaped like keys, to invade human cells. However, these spike proteins undergo modifications before interacting with human cells.

The virus relies on human enzymes to mutate and change the shape of its spike proteins, as it lacks its own enzymes to facilitate this process. A recent study has identified the human enzyme KLK5 as a crucial player in the transformation of these spike proteins.

According to Dr. Choi Young-ki, Director of the Korea Virus Research Institute, “For the COVID-19 virus to enter human cells, two specific sites on the spike protein must be cleaved. Our research has confirmed that KLK5 plays a vital role in enabling the virus to bind to human cells.”

This breakthrough has significant implications for the development of COVID-19 treatments. By inhibiting the KLK5 enzyme, researchers may be able to create a new class of treatments that prevent the virus from entering human cells. Current treatments, such as Paxrovid, work by inhibiting the proliferation of the virus after it has already infected cells.

The research team is now focused on discovering a therapeutic substance that can inhibit the KLK5 enzyme, with the ultimate goal of developing a domestically produced COVID-19 treatment. While this process may take time, the potential for a new treatment modality has garnered significant attention.

This discovery highlights the importance of continued research into the COVID-19 virus and its behavior. As the world continues to grapple with the pandemic, breakthroughs like this one offer hope for the development of more effective treatments and, ultimately, a better understanding of the virus itself.